De Candia, Erica
 Distribuzione geografica
Continente #
EU - Europa 1.753
NA - Nord America 1.643
AS - Asia 307
OC - Oceania 13
SA - Sud America 12
AF - Africa 9
Continente sconosciuto - Info sul continente non disponibili 3
Totale 3.740
Nazione #
US - Stati Uniti d'America 1.624
SE - Svezia 365
PL - Polonia 363
DE - Germania 321
IT - Italia 178
CN - Cina 177
UA - Ucraina 135
IE - Irlanda 126
FR - Francia 90
GB - Regno Unito 63
IN - India 40
BE - Belgio 30
FI - Finlandia 30
IR - Iran 18
TR - Turchia 18
JP - Giappone 14
AU - Australia 12
HU - Ungheria 11
BR - Brasile 10
MX - Messico 10
CA - Canada 8
VN - Vietnam 7
AT - Austria 6
MY - Malesia 6
NL - Olanda 6
RO - Romania 6
IL - Israele 5
CH - Svizzera 4
ES - Italia 4
MK - Macedonia 4
RU - Federazione Russa 4
A2 - ???statistics.table.value.countryCode.A2??? 3
CI - Costa d'Avorio 3
EG - Egitto 3
ID - Indonesia 3
PK - Pakistan 3
GR - Grecia 2
IQ - Iraq 2
JO - Giordania 2
MN - Mongolia 2
PH - Filippine 2
ZA - Sudafrica 2
AE - Emirati Arabi Uniti 1
AM - Armenia 1
BZ - Belize 1
CL - Cile 1
EC - Ecuador 1
EE - Estonia 1
HK - Hong Kong 1
HR - Croazia 1
KZ - Kazakistan 1
LT - Lituania 1
MD - Moldavia 1
NG - Nigeria 1
NZ - Nuova Zelanda 1
RS - Serbia 1
SA - Arabia Saudita 1
SG - Singapore 1
SY - Repubblica araba siriana 1
TW - Taiwan 1
Totale 3.740
Città #
Warsaw 361
Chandler 333
Dublin 121
Fairfield 106
San Mateo 90
Wilmington 83
Jacksonville 66
Woodbridge 62
Ashburn 61
Ann Arbor 59
Nanjing 54
Houston 45
Boston 43
Marseille 42
Seattle 42
Princeton 36
Dearborn 33
Brussels 30
Cambridge 28
Cattolica 28
Redwood City 28
Rome 26
Beijing 24
Lawrence 20
Nanchang 18
Boardman 13
Redmond 13
Andover 12
Augusta 12
Hangzhou 12
Milan 12
Nürnberg 12
Izmir 11
Norwalk 11
Bremen 10
Budapest 10
Chicago 10
London 10
Mountain View 10
San Diego 10
Zhengzhou 10
Hebei 8
Kunming 7
Shenyang 7
University Park 7
Cuauhtémoc 6
Kish 6
Putrajaya 6
San Jose 6
Ypsilanti 6
Changsha 5
Dong Ket 5
Florence 5
Kocaeli 5
Sydney 5
Bari 4
Hefei 4
Leawood 4
Perugia 4
Prilep 4
Tustin 4
Abidjan 3
Bonn 3
Brisbane 3
Buffalo 3
Castelnuovo Rangone 3
Chiswick 3
Detroit 3
Esslingen am Neckar 3
Genzano Di Roma 3
Guangzhou 3
Hadera 3
Hyderabad 3
Islington 3
Jakarta 3
Jiaxing 3
Jinan 3
Menlo Park 3
Monza 3
Ottawa 3
San Cesareo 3
Shanghai 3
Southend 3
São Paulo 3
Timisoara 3
Tokyo 3
Vienna 3
Aigaleo 2
Amersham 2
Ardabil 2
Bengaluru 2
Bern 2
Bochum 2
Brighton 2
Chatsworth 2
Chiari 2
Clearwater 2
Edinburgh 2
Fremont 2
Fukuoka 2
Totale 2.229
Nome #
Abnormal proplatelet formation and emperipolesis in cultured human megakaryocytes from gray platelet syndrome patients 272
Bleeding risk of surgery and its prevention in patients with inherited platelet disorders. The Surgery in Platelet disorders And Therapeutic Approach (SPATA) study 215
Eltrombopag for the treatment of inherited thrombocytopenias: a phase 2 clinical trial 143
Murine platelet production is suppressed by S1P release in the hematopoietic niche, not facilitated by blood S1P sensing. 123
Megakaryocytic emperipolesis and platelet function abnormalities in five patients with gray platelet syndrome 122
COVID-19 and haemostasis: a position paper from Italian Society on Thrombosis and Haemostasis (SISET) 121
Thromboelastography clot strength profiles and effect of systemic anticoagulation in COVID-19 acute respiratory distress syndrome: a prospective, observational study 119
Data on the application of early coagulation support protocol in the management of major trauma patients 107
Effect of fibrinogen concentration on the velocity of platelet aggregation. 99
Structural and funtional mapping of the thrombin domain involved in the binding to the platelet glycoprotein Ib 84
Functional role of protease activated receptors in vascular biology 75
Increased platelet-fibrinogen affinity in patients with myeloproliferative disorders. 74
Effects of unfractionated and low molecular weight heparins on platelet thromboxane biosynthesis "in vivo" 73
Defective platelet responsiveness to thrombin and protease-activated receptors agonists in a novel case of gray platelet syndrome: correlation between the platelet defect and the alpha-granule content in the patient and four relatives 72
Impact of Gut Microbiota on Obesity, Diabetes, and Cardiovascular Disease Risk 72
Portal vein thrombosis occurrence in a cirrhotic patient during treatment with rivaroxaban 68
Mechanisms of platelet activation by thrombin: a short history 67
Nonalcoholic fatty liver disease (NAFLD) severity is associated to a nonhemostatic contribution and proinflammatory phenotype of platelets 67
Lymph node blast crisis in chronic myeloid leukemia mimicking T-immunoblastic lymphoma. 64
Allosteric equilibria in the binding reaction of fibrinogen to platelets. 64
NETosis in arterial and venous thrombosis: a one size fits all mechanism? 62
Carbamazepine interaction with direct oral anticoagulants: help from the laboratory for the personalized management of oral anticoagulant therapy 61
Safety of antithrombotic therapy in subjects with hereditary hemorrhagic telangiectasia: prospective data from a multidisciplinary working group 60
Heparin induced thrombocytopenia: Position paper from the Italian Society on Thrombosis and Haemostasis (SISET) 59
Thrombin-thrombomodulin interaction: energetics and potential role of water as an allosteric effector. 58
Ibrutinib does not affect ristocetin-induced platelet aggregation evaluated by light transmission aggregometry in chronic lymphocytic leukemia patients 58
Direct oral anticoagulants and therapeutic adherence: do not let your guard down 58
Autoimmune disorders of platelet function: systematic review of cases of acquired Glanzmann thrombasthenia and acquired delta storage pool disease 58
Hepatocellular carcinoma complicating liver cirrhosis in type IIIa glycogen storage disease. 56
Correlation between platelet phenotype and NBEAL2 genotype in patients with congenital thrombocytopenia and α-granule deficiency 55
Hemophilia A and von Willebrand deficiency: therapeutic implications 54
INHIBITION OF FIBRINOGEN BINDING TO HUMAN-PLATELETS BY BLOCKAGE OF NA+/H+ EXCHANGE. 52
Does chronic oral anticoagulation reduce in-hospital mortality among COVID-19 older patients? 52
Detection of Platelet-Activating Antibodies Associated with Vaccine-Induced Thrombotic Thrombocytopenia by Flow Cytometry: An Italian Experience 51
Thrombin interaction with platelet GpIB: role of the heparin binding domain. 50
Megakaryocytic emperipolesis and platelet function abnormalities in five patients with gray platelet syndrome 50
Carbamazepine interaction with direct oral anticoagulants: help from the laboratory for the personalized management of oral anticoagulant therapy 50
Noncanonical type 2B von Willebrand disease associated with mutations in the VWF D9D3 and D4 domains 48
Management of bleeding and of invasive procedures in patients with platelet disorders and/or thrombocytopenia:Guidelines of the Italian Society for Haemostasis and Thrombosis (SISET) 47
Rituximab for treatment of autoimmune acquired platelet function disorders: description of two cases of acquired Glanzmann thrombasthenia and one case of acquired delta storage pool disease 47
Binding of human alpha-thrombin to platelet GpIb: energetics and functional effects. 46
Early coagulation support protocol: A valid approach in real-life management of major trauma patients. Results from two Italian centres 46
Analysis of 339 pregnancies in 181 women with 13 different forms of inherited thrombocytopenia 45
Consensus statements on vaccination in patients with haemophilia—Results from the Italian haemophilia and vaccinations (HEVA) project 45
Nonalcoholic fatty liver disease (NAFLD) severity is associated to a nonhemostatic contribution and proinflammatory phenotype of platelets 45
Validation of the ISTH/SSC bleeding assessment tool for inherited platelet disorders: A communication from the Platelet Physiology SSC 43
The ISTH bleeding assessment tool as predictor of bleeding events in inherited platelet disorders: Communication from the ISTH SSC Subcommittee on Platelet Physiology 43
MYH9-Related Disease: A Novel Prognostic Model to Predict the Clinical Evolution of the Disease Based on Genotype-Phenotype Correlations 41
MYH9-Related Disease: A Novel Prognostic Model to Predict the Clinical Evolution of the Disease Based on Genotype-Phenotype Correlations 40
Novel manifestations of immune dysregulation and granule defects in gray platelet syndrome 39
Antithrombotic prophylaxis for surgery-associated venous thromboembolism risk in patients with inherited platelet disorders. The SPATA-DVT Study 38
Prevalence and significance of anti-prothrombin (aPT) antibodies in patients with Lupus Anticoagulant (LA). 35
Platelet diameters in inherited thrombocytopenias: analysis of 376 patients with all known disorders 35
Protective effect of oral anticoagulant drugs in atrial fibrillation patients admitted for COVID-19: Results from the CORIST study 30
Why the disorder induced by GATA1 Arg216Gln mutation should be called "X-linked thrombocytopenia with thalassemia" rather than "X-linked gray platelet syndrome 22
Defective platelet responsiveness to thrombin and protease-activated receptors agonists in a novel case of gray platelet syndrome: correlation between the platelet defect and the alpha-granule content in the patient and four relatives 18
Extended coagulation profile of children with Long Covid: a prospective study 10
D-dimer and reduced-dose apixaban for extended treatment after unprovoked venous thromboembolism: the Apidulcis study 7
Bleeding and thrombotic events in a patient with lupus anticoagulant-associated hypoprothrombinemia and antiphospholipid antibody syndromes: managing hemostasis between Scylla and Charybdis 6
Evaluation of Novel Guanidino-Containing Isonipecotamide Inhibitors of Blood Coagulation Factors against SARS-CoV-2 Virus Infection 4
Totale 3.825
Categoria #
all - tutte 11.148
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 11.148


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019217 0 0 8 9 20 21 47 14 23 27 29 19
2019/2020623 77 21 29 31 20 55 88 29 52 36 104 81
2020/2021579 29 68 12 64 70 73 46 21 50 44 90 12
2021/2022658 44 82 22 39 34 18 18 111 23 39 112 116
2022/20231.065 141 135 71 141 85 126 78 87 129 14 40 18
2023/2024228 21 187 20 0 0 0 0 0 0 0 0 0
Totale 3.825